Im, S., Rojas, C., Victoria, I., Ahn, J., Park, J. J., Reyes, F., Curigliano, G., Edmondson, M., Myer, N., Bear, A. S., Chen, M., Spreafico, A. (2025). Phase 1 study of the anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody (mAb) MK-0482 + pembrolizumab (pembro) + paclitaxel for previously untreated advanced triple negative breast cancer (TNBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13135